Key result
Protocol outlines upcoming network meta-analysis to evaluate optimal DAPT de-escalation in post-PCI ACS patients.
Why the study?
The optimal DAPT de-escalation strategy in terms of duration and type of therapy for patients with ACS treated with PCI remains to be identified.
What is the optimal de-escalation strategy in terms of duration and type of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention?
Meta-Analysis
What is the optimal de-escalation strategy in terms of duration and type of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
This is a protocol for a network meta-analysis to evaluate the optimal duration and type of dual antiplatelet therapy de-escalation in patients with ACS undergoing PCI.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Filippo et al. (2021) conducted a meta-analysis in Acute coronary syndrome after percutaneous coronary intervention. De-escalation of dual antiplatelet therapy was evaluated. This is a protocol for a network meta-analysis to evaluate the optimal duration and type of dual antiplatelet therapy de-escalation for patients with acute coronary syndrome treated with PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: